One of China's National Leaders in Thoracic Surgery & Esophageal Cancer Surgery
The Department of Thoracic Surgery at Shanghai Chest Hospital — affiliated with Shanghai Jiao Tong University School of Medicine — is one of China's most distinguished and nationally recognized thoracic surgery centers, with a particular national reputation for excellence in esophageal cancer surgery, lung cancer surgery, mediastinal tumor surgery, minimally invasive thoracic surgery, and the management of complex thoracic conditions. As one of China's highest-volume esophageal cancer surgery programs and a dedicated thoracic specialty hospital, Shanghai Chest Hospital combines outstanding surgical expertise with a world-class research program, offering international patients access to some of China's most eminent thoracic surgeons. China Medical Concierge Shanghai (CMCS) provides seamless end-to-end coordination for international patients throughout their thoracic surgical care journey.
About the Department
The thoracic surgery department is a national key clinical specialty operating dedicated thoracic surgery wards, multiple robotic and VATS operating theaters (da Vinci Xi), an enhanced recovery after surgery (ERAS) program, a multidisciplinary thoracic oncology tumor board, an esophageal disease center, and works in close collaboration with pulmonary medicine, radiation oncology, medical oncology, cardiology, and pathology through a fully integrated multidisciplinary team.
Faculty members publish regularly in leading thoracic surgery journals including Journal of Thoracic and Cardiovascular Surgery, Annals of Thoracic Surgery, European Journal of Cardio-Thoracic Surgery, Journal of Thoracic Oncology, and Diseases of the Esophagus.
Esophageal Cancer Surgery
Shanghai Chest Hospital's esophageal cancer surgery program is one of China's most experienced and highest-volume:
Minimally Invasive Esophagectomy (MIE)
- Thoracoscopic-Laparoscopic Ivor Lewis MIE — Two-field approach; intrathoracic anastomosis; one of China's highest-volume Ivor Lewis MIE programs; reduced pulmonary complications vs. open; MIRO trial evidence
- McKeown MIE (Three-Field) — Thoracoscopic + laparoscopic + cervical anastomosis; for upper and mid-thoracic esophageal cancer; three-field lymphadenectomy; one of China's most experienced McKeown MIE programs
- Robotic Esophagectomy — da Vinci Xi robotic Ivor Lewis and McKeown; superior mediastinal dissection; 3D visualization; wristed instruments; reduced anastomotic leak; one of China's most experienced robotic esophagectomy programs
- Single-Port VATS Esophagectomy — Uniportal thoracoscopic esophagectomy; minimal access; reduced chest wall trauma
- ERAS for Esophagectomy — Pre-operative nutrition optimization; epidural analgesia; early oral feeding; early mobilization; reduced hospital stay
Esophageal Reconstruction
- Gastric Conduit — Whole stomach and gastric tube conduit; pyloric drainage (pyloroplasty, pyloromyotomy, botulinum toxin); one of China's most experienced gastric conduit programs
- Colonic Interposition — For salvage esophagectomy after prior gastric surgery; left and right colon; isoperistaltic and antiperistaltic
- Jejunal Free Flap — For pharyngoesophageal reconstruction after laryngopharyngectomy; coordination with head and neck surgery
Neoadjuvant & Adjuvant Therapy
- CROSS Protocol — Carboplatin + paclitaxel + concurrent radiation (41.4 Gy) for SCC and adenocarcinoma; pathological complete response (pCR) as surrogate endpoint; one of China's most experienced CROSS protocol programs
- FLOT Perioperative Chemotherapy — For esophagogastric junction (EGJ) adenocarcinoma; docetaxel + oxaliplatin + leucovorin + 5-FU; FLOT4 trial evidence
- Neoadjuvant Immunotherapy — Nivolumab + chemotherapy (CheckMate 648); pembrolizumab + chemotherapy (KEYNOTE-590); sintilimab + chemotherapy; camrelizumab + chemotherapy; pCR rates with immunotherapy combinations
- Adjuvant Nivolumab — CheckMate 577: adjuvant nivolumab for residual disease after neoadjuvant CRT + surgery; 1 year of adjuvant immunotherapy
- Watch-and-Wait — For clinical complete response (cCR) after neoadjuvant CRT; active surveillance protocol; salvage esophagectomy for recurrence; one of China's most experienced watch-and-wait programs
Advanced & Recurrent Esophageal Cancer
- Salvage Esophagectomy — After definitive chemoradiation; technically demanding; one of China's most experienced salvage esophagectomy programs
- Palliative Procedures — Esophageal stenting; gastrostomy; jejunostomy; bypass surgery; coordination with interventional endoscopy
- Recurrent Disease — Pembrolizumab for PD-L1-positive (KEYNOTE-181); nivolumab (ATTRACTION-3); trastuzumab deruxtecan (T-DXd) for HER2-positive; zolbetuximab for CLDN18.2-positive
Lung Cancer Surgery
Minimally Invasive Lung Resection
- Uniportal VATS — Single-port VATS lobectomy, segmentectomy, and wedge resection; one of China's most experienced uniportal VATS programs; minimal trauma; rapid recovery
- Robotic Lung Resection — da Vinci Xi robotic lobectomy and segmentectomy; 3D visualization; one of China's most experienced robotic lung resection programs
- Anatomic Segmentectomy — For small peripheral tumors (≤2cm) and GGO-dominant lesions; JCOG0802 evidence; one of China's most experienced segmentectomy programs
- Sleeve Lobectomy — Bronchial and vascular sleeve resection; lung-sparing; VATS and robotic sleeve; one of China's most experienced sleeve resection programs
- Extended Resection — Chest wall; superior sulcus (Pancoast); pericardium; vascular reconstruction
Adjuvant & Neoadjuvant Therapy Integration
- Adjuvant Osimertinib — ADAURA trial; EGFR-mutated stage IB-IIIA NSCLC; 3 years post-surgery
- Adjuvant Alectinib — ALINA trial; ALK-positive NSCLC; 2 years post-surgery
- Neoadjuvant Immunotherapy — Nivolumab + chemotherapy (CheckMate 816); pembrolizumab + chemotherapy (KEYNOTE-671); pCR endpoint
- LAURA Trial — Osimertinib after CRT for unresectable EGFR-mutated stage III NSCLC
Mediastinal Tumors
- Thymoma & Thymic Carcinoma — VATS and robotic thymectomy for early-stage; extended thymectomy for myasthenia gravis; open resection for advanced; pembrolizumab for thymic carcinoma; one of China's most experienced thymoma programs
- Mediastinal Germ Cell Tumors — BEP chemotherapy; post-chemotherapy resection; coordination with oncology
- Neurogenic Tumors — VATS and robotic resection; dumbbell tumors: coordination with neurosurgery
- Mediastinal Cysts — Bronchogenic; pericardial; enteric; VATS resection
Pleural Disease
- Malignant Pleural Mesothelioma (MPM) — VATS pleurectomy/decortication (P/D); EPP for selected cases; nivolumab + ipilimumab (CheckMate 743); pembrolizumab; IMRT coordination
- Malignant Pleural Effusion — VATS pleurodesis; indwelling pleural catheter (PleurX); talc poudrage
- Empyema — VATS decortication; fibrinolytic therapy; open decortication for chronic empyema
- Spontaneous Pneumothorax — VATS bullectomy and pleurodesis; uniportal VATS; recurrence prevention
Chest Wall Surgery
- Chest Wall Tumors — Wide resection; prosthetic reconstruction (titanium mesh, PEEK); soft tissue reconstruction; one of China's most experienced chest wall tumor programs
- Pectus Excavatum — Nuss procedure (minimally invasive); Ravitch procedure; one of China's most experienced Nuss programs
- Chest Wall Trauma — Rib fixation; flail chest stabilization; coordination with trauma surgery
Why International Patients Choose Shanghai Chest Hospital Thoracic Surgery
- China's Premier Esophageal Cancer Surgery Center — One of China's highest-volume esophageal cancer surgery programs; robotic and MIE expertise; watch-and-wait for cCR
- Robotic Esophagectomy — One of China's most experienced robotic esophagectomy programs; reduced anastomotic leak; superior mediastinal dissection
- Adjuvant Nivolumab (CheckMate 577) — Post-neoadjuvant CRT + surgery for residual esophageal cancer; 1-year adjuvant immunotherapy
- Zolbetuximab for CLDN18.2-Positive — Claudin 18.2-targeted therapy for EGJ adenocarcinoma
- Sleeve Lobectomy Expertise — One of China's most experienced VATS and robotic sleeve resection programs; lung-sparing surgery
- Cost-Effectiveness — World-class thoracic surgery at significantly lower cost than equivalent treatment in Western countries
The CMCS Patient Journey
- Initial Inquiry — Share your thoracic diagnosis, CT chest imaging, PET-CT, endoscopy and EUS reports, pulmonary function tests, and prior treatment history with CMCS.
- Medical Record Preparation — We translate and organize your records for specialist pre-consultation review.
- Specialist Matching — We identify the most appropriate thoracic surgeon based on your condition — esophageal cancer, lung cancer, mediastinal tumor, pleural disease, or chest wall surgery.
- MDT Submission — We facilitate pre-arrival case review by the multidisciplinary thoracic oncology tumor board.
- Priority Scheduling — We secure a consultation and surgical slot with minimal waiting time.
- Travel & Logistics — Assistance with visa invitation letters, accommodation near Shanghai Chest Hospital, and Shanghai airport transfers.
- Surgical Coordination — Full coordination of pre-operative assessment, nutritional optimization, surgical admission, and ERAS program enrollment.
- Post-Operative Follow-Up — Surgical report translation, pathology result interpretation, adjuvant therapy coordination, and remote follow-up after you return home.
Book a Consultation
If you have esophageal cancer, lung cancer, a mediastinal tumor, a pleural condition, or any thoracic surgical condition — CMCS can arrange a specialist consultation with Shanghai Chest Hospital's thoracic surgery team.
📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com
0 comentarios